Aclaris Therapeutics Net Profit Margin 2014-2020 | ACRS

Aclaris Therapeutics net profit margin from 2014 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Aclaris Therapeutics Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.01B $-0.10B -2040.00%
2020-03-31 $0.00B $-0.14B -3500.00%
2019-12-31 $0.00B $-0.16B -4050.00%
2019-09-30 $0.01B $-0.18B -3640.00%
2019-06-30 $0.01B $-0.16B -3200.00%
2019-03-31 $0.01B $-0.14B -1762.50%
2018-12-31 $0.01B $-0.13B -1662.50%
2018-09-30 $0.01B $-0.12B -1671.43%
2018-06-30 $0.01B $-0.10B -1457.14%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.110B $0.004B
Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.575B 44.69
Takeda Pharmaceutical (TAK) Japan $56.245B 9.80
Astellas Pharma (ALPMY) Japan $27.759B 14.07
Eisai (ESALY) Japan $27.124B 22.92
UCB SA (UCBJF) Belgium $22.660B 0.00
Merck (MKGAF) Germany $18.973B 24.88
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $14.092B 45.81
Grifols, S.A (GRFS) Spain $11.929B 14.58
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $8.967B 34.72
IPSEN SA ADR (IPSEY) France $8.717B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.931B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.908B 13.08
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Ionis Pharmaceuticals (IONS) United States $6.629B 41.99
United Therapeutics (UTHR) United States $4.486B 10.37
Arrowhead Pharmaceuticals (ARWR) United States $4.405B 0.00
Evotec AG (EVTCY) Germany $4.022B 139.60
ChemoCentryx (CCXI) United States $3.775B 0.00
FibroGen (FGEN) United States $3.715B 0.00
Hypermarcas (HYPMY) Brazil $3.329B 12.24
Sage Therapeutics (SAGE) United States $3.177B 0.00
PTC Therapeutics (PTCT) United States $3.165B 0.00
Nektar Therapeutics (NKTR) United States $2.968B 0.00
Pacira BioSciences (PCRX) United States $2.570B 67.55
Revolution Medicines (RVMD) United States $2.294B 0.00
Xencor (XNCR) United States $2.220B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.098B 10.16
Corcept Therapeutics (CORT) United States $2.011B 18.52
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.860B 0.00
Cronos Group (CRON) Canada $1.753B 0.00
USANA Health Sciences (USNA) United States $1.548B 14.58
Ironwood Pharmaceuticals (IRWD) United States $1.439B 9.99
Trillium Therapeutics (TRIL) Canada $1.398B 0.00
Heron Therapeutics (HRTX) United States $1.346B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.163B 11.09
Indivior (INVVY) United States $1.152B 14.27
Karyopharm Therapeutics (KPTI) United States $1.073B 0.00
Esperion Therapeutics (ESPR) United States $1.034B 0.00
Translate Bio (TBIO) United States $1.010B 0.00
Zogenix (ZGNX) United States $0.994B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.946B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.919B 572.25
Vectura Group (VEGPF) United Kingdom $0.828B 0.00
Endo (ENDP) Ireland $0.758B 1.12
VAXART, INC (VXRT) United States $0.726B 0.00
Collegium Pharmaceutical (COLL) United States $0.719B 0.00
ImmunoGen (IMGN) United States $0.628B 0.00
Tilray (TLRY) Canada $0.617B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.607B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.595B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.575B 0.00
Aerie Pharmaceuticals (AERI) United States $0.547B 0.00
Molecular Templates (MTEM) United States $0.545B 0.00
Siga Technologies (SIGA) United States $0.537B 57.25
Radius Health (RDUS) United States $0.527B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.515B 0.00
Flexion Therapeutics (FLXN) United States $0.513B 0.00
Ocular Therapeutix (OCUL) United States $0.479B 0.00
Ardelyx (ARDX) United States $0.468B 0.00
Altimmune (ALT) United States $0.434B 0.00
TherapeuticsMD (TXMD) United States $0.430B 0.00
Harpoon Therapeutics (HARP) United States $0.427B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.405B 0.00
Organogenesis Holdings (ORGO) United States $0.405B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.388B 19.35
Redhill Biopharma (RDHL) Israel $0.360B 0.00
Akebia Therapeutics (AKBA) United States $0.360B 0.00
MEI Pharma (MEIP) United States $0.351B 0.00
DURECT (DRRX) United States $0.343B 0.00
PROFOUND MEDICL (PROF) Canada $0.343B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.307B 7.62
Innate Pharma SA (IPHYF) France $0.298B 0.00
IMV INC (IMV) Canada $0.297B 0.00
Concert Pharmaceuticals (CNCE) United States $0.291B 0.00
Menlo Therapeutics (VYNE) United States $0.278B 0.00
Jounce Therapeutics (JNCE) United States $0.278B 13.16
Xeris Pharmaceuticals (XERS) United States $0.274B 0.00
Lannett Co Inc (LCI) United States $0.246B 5.71
Rafael Holdings (RFL) United States $0.245B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
Nature's Sunshine Products (NATR) United States $0.226B 22.25
KalVista Pharmaceuticals (KALV) United States $0.225B 0.00
Nivalis Therapeutics (ALPN) United States $0.209B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.206B 0.00
Otonomy (OTIC) United States $0.195B 0.00
CASI Pharmaceuticals (CASI) United States $0.190B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.189B 0.00
Heat Biologics (HTBX) United States $0.184B 0.00
OptiNose (OPTN) United States $0.179B 0.00
Taiwan Liposome (TLC) Taiwan $0.165B 0.00
Aquestive Therapeutics (AQST) United States $0.163B 0.00
CTI BioPharma (CTIC) United States $0.158B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.152B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.147B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.128B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.127B 0.00
Champions Oncology (CSBR) United States $0.118B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.110B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.110B 0.00
MediWound (MDWD) Israel $0.102B 0.00
Lipocine (LPCN) United States $0.093B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
Biomerica (BMRA) United States $0.081B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.078B 0.00
ElectroCore (ECOR) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.075B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.071B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.070B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.069B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.067B 0.00
Novan (NOVN) United States $0.066B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.058B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.056B 0.00
CV Sciences (CVSI) United States $0.053B 0.00
Onconova Therapeutics (ONTX) United States $0.050B 0.00
Recro Pharma (REPH) United States $0.050B 0.00
Natural Alternatives (NAII) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.18
SCYNEXIS (SCYX) United States $0.047B 0.00
India Globalization Capital (IGC) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
PolarityTE (PTE) United States $0.040B 0.00
IsoRay (ISR) United States $0.040B 0.00
ProPhase Labs (PRPH) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.96
GTx (ONCT) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.033B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.032B 0.00
AgeX Therapeutics (AGE) United States $0.031B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Neos Therapeutics (NEOS) United States $0.026B 0.00
Sundial Growers (SNDL) Canada $0.026B 0.00
Vical (BBI) United States $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.022B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 22.27
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
China SXT Pharmaceuticals (SXTC) China $0.008B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00